Atlas Trials

Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer

Clinical trial NCT03506048 · TERMINATED

Trial details

NCT number
NCT03506048
Sponsor
Emory University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Differentiated Thyroid Gland CarcinomaThyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma
Start date
2019-01-16
Primary completion
2021-06-24
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.